Zoetis Inc. (ZTS)

82.79
2.03 2.51
NYSE : Health Technology
Prev Close 80.76
Open 81.20
Day Low/High 81.00 / 82.93
52 Wk Low/High 52.25 / 81.78
Volume 2.66M
Avg Volume 2.41M
Exchange NYSE
Shares Outstanding 487.29M
Market Cap 38.85B
EPS 1.80
P/E Ratio 46.00
Div & Yield 0.50 (0.55%)

Latest News

Chart of the Day: Is Campbell Soup in a Death Spiral?

Chart of the Day: Is Campbell Soup in a Death Spiral?

Both of these stocks are in the news this week. One is of a rising star, the other has been a real dog.

Maybe This Is Not Really About Inflation -- Market Recon

Maybe This Is Not Really About Inflation -- Market Recon

Overreaction seems to be what markets are good at in this 'golden age of electronic trading.'

Zoetis Reports Fourth Quarter And Full Year 2017 Results

Zoetis Reports Fourth Quarter And Full Year 2017 Results

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2017 and provided full year guidance for 2018.

Zoetis Declares Second Quarter 2018 Dividend

Zoetis Declares Second Quarter 2018 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2018 dividend payable to holders of the company's common stock of $0.

Zoetis To Participate In The Bank Of America Merrill Lynch Animal Health Summit

Zoetis To Participate In The Bank Of America Merrill Lynch Animal Health Summit

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

How to Play Eight Potential Breakout Stocks

How to Play Eight Potential Breakout Stocks

A partial list of names that are showing signs of breaking out Monday.

Zoetis Becomes #178 Most Shorted S&P 500 Component, Replacing Advance Auto Parts

The most recent short interest data has been released for the 12/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Zoetis To Host Webcast And Conference Call On Fourth Quarter And Full Year 2017 Financial Results

Zoetis To Host Webcast And Conference Call On Fourth Quarter And Full Year 2017 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis To Participate In The 36th Annual J.P. Morgan Healthcare Conference

Zoetis To Participate In The 36th Annual J.P. Morgan Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the 36th Annual J.

Zoetis Launches Vanguard® CIV H3N2/H3N8 Vaccine For Canine Influenza Virus

Zoetis Launches Vanguard® CIV H3N2/H3N8 Vaccine For Canine Influenza Virus

Zoetis today announced the launch of Vanguard ® CIV H3N2/H3N8, the latest vaccine in the company's canine influenza virus (CIV) portfolio.

Zoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment Increase

Zoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment Increase

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2018 dividend payable to holders of the company's common stock of $0.

Zoetis Moves Up In Analyst Rankings, Passing Prologis

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #110 spot from Prologis Inc , according to ETF Channel. Below is a chart of Zoetis Inc versus Prologis Inc plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; PLD plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Zoetis Announces Third Quarter 2017 Results

Zoetis Announces Third Quarter 2017 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2017 and raised its full year guidance for revenue and net income.

My Trader Side Prefers Jay Powell; My Economist Side Likes Rules: Market Recon

My Trader Side Prefers Jay Powell; My Economist Side Likes Rules: Market Recon

My economist side would clearly prefer a rules-based approach toward monetary policy.

Eli Lilly Reports Top-and-Bottom-Line Beat

We believe that the quality of the quarter, with strong growth and value creation opportunities, promotes optimism in the company.

The New #157 Most Shorted S&P 500 Component: Zoetis

The New #157 Most Shorted S&P 500 Component: Zoetis

The most recent short interest data has been released for the 09/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Zoetis To Participate In The Credit Suisse Healthcare Conference

Zoetis To Participate In The Credit Suisse Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse Healthcare Conference on Tuesday, Nov.

Zoetis Declares Fourth Quarter 2017 Dividend

Zoetis Declares Fourth Quarter 2017 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2017 dividend payable to holders of the company's common stock of $0.

Zoetis To Host Webcast And Conference Call On Third Quarter 2017 Financial Results

Zoetis To Host Webcast And Conference Call On Third Quarter 2017 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis Named A Top Ten Company For Working Mothers

Zoetis Named A Top Ten Company For Working Mothers

Zoetis Inc. (NYSE:ZTS) today announced that it has been named one of the top ten companies on Working Mother magazine's "100 Best Companies for Working Mothers" list.

Zoetis To Participate In The Cantor Fitzgerald Global Healthcare Conference

Zoetis To Participate In The Cantor Fitzgerald Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Cantor Fitzgerald Global Healthcare Conference on Tuesday, Sept.

Zoetis Announces Pricing Of $1.25 Billion Of Senior Notes

Zoetis Announces Pricing Of $1.25 Billion Of Senior Notes

Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

What are the chances of a Draghi dovish surprise? I wouldn't bet the farm on anything.

Zoetis Announces Second Quarter 2017 Results

Zoetis Announces Second Quarter 2017 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2017 and increased its full year guidance for revenue and net income.

Zoetis Appoints Dr. Linda Rhodes To Board Of Directors

Zoetis Appoints Dr. Linda Rhodes To Board Of Directors

Zoetis Inc. (NYSE: ZTS) today announced the appointment of Dr.

Zoetis Completes Acquisition Of Nexvet Biopharma

Zoetis Completes Acquisition Of Nexvet Biopharma

Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)...

TheStreet Quant Rating: B+ (Buy)